Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00868036 · ClinicalTrials.gov registry record
Evaluating for Contact Allergies in Patients With Chronic Urticaria
A clinical trial of Allergy and Dermatitis, sponsored by Tufts Medical Center.
- Completed
- Registry status
- 23
- Enrollment target
- 1
- Study location
NCT00868036: Completed study of Allergy and Dermatitis, sponsored by Tufts Medical Center.
NCT00868036 is a study of Allergy and Dermatitis that has completed, run by Tufts Medical Center. The registered enrollment target is 23 participants, below the 331-participant average among 15 other Allergy trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00868036, a study of Allergy and Dermatitis, has completed, sponsored by Tufts Medical Center.
- COMPLETED
- Registry status
- 23 participants
- Enrollment target
- 1
- Study location
Study Summary
Hives affects 10-25% of the population worldwide at some time during their lifetime. Hives are itchy transient swellings of the skin lasting 4-36 hours. Chronic urticaria is defined as hives that have been ongoing for six weeks or more. Patch testing is performed to diagnose allergic contact dermatitis, and if contact allergens are found via patch testing, patients can often be cured of their dermatitis. However, patch testing is currently not routinely performed in the evaluation of patients with chronic idiopathic urticaria. Our hypothesis is to see if contact allergens can be identified with patch testing in patients with chronic urticaria, and, if any allergens are identified, to see if avoiding these contact allergens will make the chronic urticaria go away.
Conditions Studied
Interventions
- PROCEDURE Patch Testing
Study Locations (1)
Massachusetts
- Tufts Medical Center, Department of Dermatology - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2008-12 |
| Est. Completion | 2011-01 |
What the finished NCT00868036 record still lists
NCT00868036 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 331-participant average among 15 other Allergy trials with a reported enrollment target (93% lower).
The record links to 5 conditions, with Allergy appearing as the primary indexed condition, and to 1 intervention - of which Patch Testing is the first listed.
NCT00868036 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00868036 about?
NCT00868036 is a clinical study titled "Evaluating for Contact Allergies in Patients With Chronic Urticaria". Hives affects 10-25% of the population worldwide at some time during their lifetime. Hives are itchy transient swellings of the skin lasting 4-36 hours. Chronic urticaria is defined as hives that have been ongoing for six weeks or more. Patch testing is performed to diagnose allergic contact dermat...
What is the current status of trial NCT00868036?
This trial is currently completed. The enrollment target is 23 participants. The study started on 2008-12. Estimated completion is 2011-01.
What conditions does trial NCT00868036 study?
This clinical trial studies the following conditions: Allergy, Dermatitis, Urticaria, Patch Testing, Contact Sensitization.
What interventions are being tested in trial NCT00868036?
The interventions under investigation include: Patch Testing (PROCEDURE).
Who is sponsoring clinical trial NCT00868036?
This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00868036 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Allergy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00868036's enrollment target sits among peer trials
23 14th of 15 higher than 2 of 15 other Allergy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Allergy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Understanding Allergies and Sensitizations in Healthy and Allergic Individuals
RECRUITING
-
The Nonirritating Concentrations of Midazolam, Ketamine, and Ondansetron
RECRUITING · Phase 4
-
Safety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers)
RECRUITING · Phase 3
-
Childhood Allergy and the Neonatal Environment
ACTIVE NOT RECRUITING
-
Urban Environmental Factors and Childhood Asthma
COMPLETED
-
Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal Allergies
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia